News

Cryoport Expands FDA Compliance with MVE Biological Solutions

Cryoport Expands FDA Compliance with MVE Biological Solutions

Cryoport Strengthens Regulatory Compliance with FDA Registration

Cryoport, Inc. has made significant strides in the life sciences industry by registering all three manufacturing facilities of MVE Biological Solutions with the U.S. Food and Drug Administration (FDA). These facilities are recognized for adhering to quality standards and best practices that define the success of MVE as a leading manufacturer of high-quality cryogenic products.

Milestone Completion for MVE Biological Solutions

The three registered facilities highlight MVE's ongoing dedication to global regulatory compliance. The FDA registration also allows for the listing of MVE’s entire range of applicable cryogenic freezers and dewars. MVE sets itself apart by upholding rigorous standards that include compliance with 21 CFR Part 820 and Good Manufacturing Practices (GMP).

Commitment to Excellence

Jerrell Shelton, CEO of Cryoport, expressed pride in MVE's achievement, stating, "MVE’s achievement underscores our commitment to delivering the highest-quality and most reliable supply chain solutions for the life sciences industry. Our MVE team's dedication in providing lifesaving therapies is evident in our high standards. This FDA registration reflects our commitment to meeting and exceeding global regulatory standards."

Verification of FDA Registration

Cryoport encourages clients, customers, and partners to verify MVE's FDA registration. Interested parties can do so through the FDA's official database, or by reaching out directly to the company for assistance. Open lines of communication ensure that all stakeholders are informed about MVE's compliance status.

About Cryoport, Inc.

Cryoport, Inc. stands as a front-runner in supply chain solutions specifically tailored for cell and gene therapies. Catering to manufacturers, contract development manufacturers (CDMOs), and researchers, Cryoport delivers a comprehensive supply chain ecosystem. This ecosystem includes advanced temperature-controlled packaging, specialized bio-logistics services, and bio-storage solutions, all designed to enhance the efficiency and reliability of the supply chain.

Global Presence and Operations

With its corporate headquarters located in Nashville, the company operates across more than 50 global locations spread over 17 countries. This expansive reach facilitates the responsive supply chain systems necessary for today’s fast-paced life sciences industry.

Empowering MVE Biological Solutions

MVE Biological Solutions is recognized worldwide as a premier manufacturer of cryogenic systems, crucial for the preservation and transport of sensitive biological materials. Since its inception over six decades ago, MVE has established itself as a trusted name in cryogenic technology, preferred by biopharma firms, research institutions, and medical facilities. Their commitment to quality is evident in every product that reaches clients.

Product Distribution and Reach

With manufacturing sites in key global regions, MVE distributes its reliable cryogenic solutions to customers in 88 countries. This broad distribution network ensures that MVE remains at the forefront of innovation in cryogenic equipment.

Frequently Asked Questions

What is the significance of the FDA registration for MVE?

The FDA registration signifies that MVE’s manufacturing processes meet stringent regulatory standards, ensuring safety and quality in their cryogenic products.

How can clients verify MVE's FDA registration?

Clients can verify MVE’s FDA registration via the FDA’s official database or by contacting Cryoport directly for confirmation.

What products does MVE manufacture?

MVE manufactures a variety of cryogenic storage and shipping devices, including cryogenic freezers and dewars.

Where is Cryoport's headquarters located?

Cryoport's corporate headquarters is in Nashville, Tennessee, serving as a central hub for its global operations.

How long has MVE Biological Solutions been in operation?

MVE has been a leading manufacturer in cryogenic solutions for over 60 years, establishing a long history of innovation and trust in the industry.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Charter Investigation Puts ACP Exit Claims Under Lens

Updated Category News Views 83

Charter’s ACP hangover has grown from an operating headache into a governance question. Kahn Swick & Foti said on November 20, 2026, that it has begun investigating whether Charter Communications officers or directors breached fiduciary duties or otherwise broke state or federal law. That is not a finding of wrongdoing, and investors ought to keep that distinction...

Continue Reading
Mason Adds Nonprofit Expertise to Institutional Bench

Updated Category News Views 110

Endowment committees rarely need more noise; they need somebody who has actually sat through the uncomfortable votes. Mason Investment Advisory Services has hired Rebecca “Becky” Farnsworth, CFA, as a senior investment consultant, and this looks like a practical addition rather than the usual chest-thumping personnel announcement. Her stated focus will be...

Continue Reading
California Stone Ban Puts a Hidden Worker Toll in View

Updated Category News Views 42

Countertops are supposed to finish a kitchen, not quietly wreck the lungs of the people cutting them. Yet California's move toward prohibiting the fabrication and installation of artificial stone containing more than 1% crystalline silica puts an ugly, long-running occupational-health problem in plain sight. This is not a story that calls for chest-thumping market talk....

Continue Reading
Tessera Delisting Leaves HLSQ in a Tougher Market Ahead

Updated Category News Views 116

November delivered a nasty little truth serum for Tessera Defense and Homeland Security: exchange status is not a cosmetic detail when the stock’s selling price has collapsed. On November 10, NYSE Regulation suspended trading in the company’s common shares on NYSE American and began delisting proceedings. By November 17, Tessera had a chance to request review by the...

Continue Reading
Jalisco’s Culinary Push Puts Tourism Strategy in Focus

Updated Category News Views 50

A destination sells itself twice: first with a memorable meal, then with a reason to come back. Jalisco’s stated effort to connect the world’s cuisines through The 50 Best Gastronomic Experiences belongs in that second category. It is not merely restaurant chatter. It reads as part of a broader attempt to make the state’s tourism offering feel deeper, more varied...

Continue Reading
Epic Blue Puts $50,000 of Marketing Work to Use Locally

Updated Category News Views 84

A $50,000 pile of donated know-how can look soft on a spreadsheet, until you remember how often a small nonprofit or early-stage outfit gets ignored because it cannot afford someone to sharpen its message. Epic Blue Marketing, a women-owned firm based in Jackson, Michigan, says it provided that amount in donated and reduced-rate marketing, communications and public...

Continue Reading
Veterinary Biologics Growth Has a Valuable Catch Ahead

Updated Category News Views 124

Pet allergies and livestock disease are hardly glamorous, yet they are becoming a durable spending lane. The veterinary biologics market is projected to rise from $2.85 billion in 2026 to $3.69 billion by 2031, a 5.3% compound annual growth rate. That is not the kind of growth figure that makes anyone pound the table, and frankly it should not. It is the sort that can...

Continue Reading
California Rideshare Data Exposes an Insurance Gap

Updated Category News Views 46

Three California counties carried an outsized share of rideshare traffic, and the insurance fine print is where this story gets uncomfortable. A review by Mendez & Sanchez says Los Angeles, San Francisco, and San Diego counties accounted for nearly two-thirds of statewide rideshare trips between September 2019 and August 2020. That is an old snapshot, sure, but it points...

Continue Reading
Delayed Remodels Can Quietly Drain Your Home's Value

Updated Category News Views 51

A pinhole leak has a nasty talent for becoming a demolition budget. That is the plain lesson in Jason Marks' discussion of delayed remodeling for homeowners in Kernersville, North Carolina. People tend to see a worn bathroom, tired kitchen, or drafty window and think, “Not pretty, but it can wait.” Sometimes it can. Sometimes that little delay lets water, rot,...

Continue Reading
BON’s Oat Lab Bet Puts Scale and Standards in Focus

Updated Category News Views 32

Oats Meet the Industrialization Problem Oats rarely make a small-cap story more interesting, yet this one has a real business nerve running through it. Bon Natural Life has teamed with China Oat Group to establish a joint laboratory aimed at biomanufacturing high-value, oat-derived natural ingredients. The headline is not simply another research collaboration. The stated...

Continue Reading

Top 5 Most Recently Viewed Articles

Disney Cruise Line Celebrates Employees as Godparents of Treasure

Updated Category News Views 97

Disney Cruise Line Celebrates Employees in Honor of Disney Treasure Disney Cruise Line is redefining maritime traditions in a beautiful manner by honoring its dedicated employees worldwide. The company’s latest announcement revealed that the honorific role of "godparent" for the new ship, the Disney Treasure, will be shared among its tremendous cast, crew, Imagineers,...

Continue Reading
Regional Management Corp. to Share Q3 2024 Financial Insights

Updated Category News Views 79

Regional Management Corp. to Announce Q3 Results Greenville, S.C. – Regional Management Corp. (NYSE: RM), a prominent player in the consumer finance sector, is set to share its financial results for the third quarter of 2024. Conference Call Details and Replay The company will report its quarterly results after market close, providing investors and stakeholders with...

Continue Reading
Suvoda Recognized as a Leader in Clinical Trial Technology

Updated Category News Views 147

Suvoda Acknowledged as a Leader in RTSM Technology Suvoda, a cutting-edge clinical trial technology company, recently shared exciting news about their IRT (Interactive Response Technology) software, which has been designated as a Leader in the prominent Everest Group's PEAK Matrix assessment for RTSM (Randomization and Trial Supply Management) technology. This recognition...

Continue Reading
Cereno Scientific Expands CS014 Focus to Combat PH-ILD

Updated Category News Views 131

Cereno Scientific Expands CS014 Focus to Combat PH-ILD Cereno Scientific, a pioneering biotech company, has made a significant announcement regarding the development focus of its HDAC inhibitor CS014. This innovative treatment is now targeting pulmonary hypertension associated with interstitial lung disease (PH-ILD), an area marked by a high level of unmet medical need....

Continue Reading
Dysmenorrhea Treatment Market Growth Insights for 2032

Updated Category News Views 188

Global Dysmenorrhea Treatment Market Insights Dysmenorrhea, commonly referred to as menstrual cramps, affects many women globally, causing significant discomfort during their menstrual cycles. Recent trends indicate that as awareness of this condition grows, so does the demand for effective treatments. The global dysmenorrhea treatment market is projected to surpass USD 8...

Continue Reading